Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
2018 · New England Journal of Medicine · 3,376 citations
https://doi.org/10.1056/nejmoa1801174
V
Vera Bittner
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
622
Papers
47.1K
Citations
96
h-index
313
i10-index
Vera Bittner is an academic researcher from University of Alabama at Birmingham Hospital. The author has contributed to research in topics: Lipoproteins and Cardiovascular Health & Cardiac Health and Mental Health & Acute Myocardial Infarction Research. The author has an h-index of 96, co-authored 529 publications.
ORCID: 0000-0001-9456-850XPapers by this author
works2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines
2023 · Circulation · 1,228 citations
https://doi.org/10.1161/cir.0000000000001168
Resistance Exercise in Individuals With and Without Cardiovascular Disease: 2007 Update
2007 · Circulation · 1,197 citations
https://doi.org/10.1161/circulationaha.107.185214
Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome
2020 · Journal of the American College of Cardiology · 545 citations
https://doi.org/10.1016/j.jacc.2019.10.057
Validity and reliability of the NYHA classes for measuring research outcomes in patients with cardiac disease
2002 · Heart & Lung · 433 citations
https://doi.org/10.1067/mhl.2002.124554
Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: Rationale and design of the ODYSSEY Outcomes trial
2014 · American Heart Journal · 409 citations
https://doi.org/10.1016/j.ahj.2014.07.028
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat